Variant report
Variant | nsv966714 |
---|---|
Chromosome Location | chr7:40576878-40581679 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-C7orf11-3 | chr7:40577726-40579281 | ENSG00000203446.2 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536934045 | chr7:40576878-40576879 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs547218993 | chr7:40576887-40576888 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566928627 | chr7:40576958-40576959 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs199695136 | chr7:40577027-40577028 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs558797100 | chr7:40577047-40577048 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs374210629 | chr7:40577098-40577099 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552350003 | chr7:40577128-40577129 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs575667006 | chr7:40577236-40577237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs537852736 | chr7:40577257-40577258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs542414257 | chr7:40577279-40577280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554503030 | chr7:40577314-40577315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189975042 | chr7:40577324-40577325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540135832 | chr7:40577331-40577332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570569407 | chr7:40577363-40577364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182236341 | chr7:40577376-40577377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576950242 | chr7:40577390-40577391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554413128 | chr7:40577393-40577394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs73308263 | chr7:40577494-40577495 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs184898183 | chr7:40577501-40577502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531392348 | chr7:40577509-40577510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541884912 | chr7:40577637-40577638 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561662816 | chr7:40577646-40577647 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530445477 | chr7:40577657-40577658 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs553550082 | chr7:40577667-40577668 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs146635299 | chr7:40577678-40577679 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs368218581 | chr7:40577726-40577727 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs190764227 | chr7:40577748-40577749 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs532619438 | chr7:40577789-40577790 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs111347678 | chr7:40577812-40577813 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs551325713 | chr7:40577840-40577841 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs569019095 | chr7:40577961-40577962 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs370694038 | chr7:40578037-40578038 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs184207965 | chr7:40578079-40578080 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs554592991 | chr7:40578122-40578123 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs141365609 | chr7:40578156-40578157 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs143784846 | chr7:40578267-40578268 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs116681231 | chr7:40578281-40578282 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs577018692 | chr7:40578284-40578285 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs145522544 | chr7:40578305-40578306 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs188711778 | chr7:40578322-40578323 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs148843264 | chr7:40578327-40578328 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs541923830 | chr7:40578442-40578443 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs367702900 | chr7:40578452-40578453 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs568524179 | chr7:40578490-40578491 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs565112624 | chr7:40578499-40578500 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs536181287 | chr7:40578519-40578520 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs193182549 | chr7:40578568-40578569 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs557209620 | chr7:40578602-40578603 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs560627045 | chr7:40578603-40578604 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs182925327 | chr7:40578604-40578605 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Autism | 22495311 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Gastric cancer | 24379144 | CNVD |
small cell lung cancer | 20016488 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:40562200-40577800 | Weak transcription | HSMM | muscle |
2 | chr7:40567600-40584600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr7:40568000-40581200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr7:40572400-40580800 | Weak transcription | NHDF-Ad | bronchial |
5 | chr7:40575800-40577200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
6 | chr7:40576600-40580000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
7 | chr7:40576800-40583800 | Weak transcription | Aorta | Aorta |
8 | chr7:40577200-40577600 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
9 | chr7:40577600-40578200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
10 | chr7:40577800-40578200 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr7:40578200-40586400 | Weak transcription | Muscle Satellite Cultured Cells | -- |
12 | chr7:40580000-40582000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
13 | chr7:40580200-40580400 | Enhancers | Ovary | ovary |
14 | chr7:40580800-40581800 | Enhancers | Osteobl | bone |
15 | chr7:40580800-40582000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
16 | chr7:40580800-40582000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
17 | chr7:40580800-40582000 | Weak transcription | Ovary | ovary |
18 | chr7:40580800-40582800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
19 | chr7:40580800-40587000 | Enhancers | NHDF-Ad | bronchial |
20 | chr7:40581000-40581800 | Enhancers | Adipose Nuclei | Adipose |
21 | chr7:40581200-40583800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
22 | chr7:40581400-40584600 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |